Latest News about CORT
Recent news which mentions CORT
Corcept Therapeutics (CORT) Q2 2022 Earnings Call Transcript
August 04, 2022
Tickers
CORT
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For August 1, 2022
August 01, 2022
From Benzinga
3 Biotech Stocks Outperforming a Bear Market
July 15, 2022
From InvestorPlace
From Benzinga
Tickers
CORT
From Motley Fool
3 Small-Cap Medical Stocks With Big Momentum
April 27, 2022
From Motley Fool
This group of stocks is flagging a rebound, and that’s good news for the S&P 500, says technical analyst
March 22, 2022
From MarketWatch
3 Reasons Why Corcept Therapeutics Is a Better Buy Than Shiba Inu Coin
February 23, 2022
Tickers
CORT
From Motley Fool
Corcept Therapeutics's Return On Capital Employed Overview
February 16, 2022
Tickers
CORT
From Benzinga
Corcept Therapeutics (CORT) Q4 2021 Earnings Call Transcript
February 16, 2022
Tickers
CORT
From Motley Fool
The Daily Biotech Pulse: Larimar Plunges On Extension Of Clinical Hold, ImmunityBio Gains On Positive Data, Adcom Test Awaits Avenue Therapeutics
February 15, 2022
From Benzinga
Earnings Scheduled For February 15, 2022
February 15, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 2, 2022
February 02, 2022
From Benzinga
2 Under-the-Radar Biotech Picks to Buy For The Long Haul
December 24, 2021
From Motley Fool
12 Health Care Stocks Moving In Friday's Intraday Session
December 10, 2021
From Benzinga
52 Biggest Movers From Yesterday
December 09, 2021
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 08, 2021
From Benzinga
35 Stocks Moving In Wednesday's Mid-Day Session
December 08, 2021
From Benzinga
Tickers
CORT
From Motley Fool
The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering
November 03, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
From Benzinga
Corcept Therapeutics' Relacorilant Combo Therapy Shows Clinical Benefit In Ovarian Cancer
September 17, 2021
Tickers
CORT
From Benzinga
The Week Ahead In Biotech (Sept. 12-18): Calliditas FDA Decision, Adcom Review For Pfizer/BioNTech COVID-19 Vaccine, Oncology Conference And IPOs
September 12, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.